Veracity Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$242K Sell
3,473
-142
-4% -$9.9K 0.08% 204
2025
Q1
$251K Buy
3,615
+30
+0.8% +$2.08K 0.1% 188
2024
Q4
$308K Sell
3,585
-1,204
-25% -$104K 0.11% 173
2024
Q3
$570K Buy
4,789
+641
+15% +$76.3K 0.22% 102
2024
Q2
$592K Sell
4,148
-1,811
-30% -$259K 0.25% 86
2024
Q1
$765K Sell
5,959
-328
-5% -$42.1K 0.3% 73
2023
Q4
$650K Sell
6,287
-105
-2% -$10.9K 0.26% 84
2023
Q3
$581K Buy
6,392
+716
+13% +$65.1K 0.27% 84
2023
Q2
$459K Sell
5,676
-106
-2% -$8.58K 0.19% 116
2023
Q1
$460K Buy
5,782
+88
+2% +$7K 0.21% 111
2022
Q4
$385K Sell
5,694
-210
-4% -$14.2K 0.18% 119
2022
Q3
$294K Sell
5,904
-28
-0.5% -$1.39K 0.16% 137
2022
Q2
$330K Buy
5,932
+1,390
+31% +$77.3K 0.18% 128
2022
Q1
$252K Buy
4,542
+92
+2% +$5.1K 0.1% 189
2021
Q4
$249K Sell
4,450
-58
-1% -$3.25K 0.1% 205
2021
Q3
$216K Buy
+4,508
New +$216K 0.09% 215
2020
Q2
Sell
-11,766
Closed -$354K 239
2020
Q1
$354K Sell
11,766
-1,510
-11% -$45.4K 0.1% 128
2019
Q4
$384K Buy
+13,276
New +$384K 0.1% 152